Savannah 2023 Pharmacology Update Conference (Recorded)

  • Registration Closed

At NPACE Pharmacology Update Conference you will fulfill your professional development and licensure needs, and access priceless context, insights, and real-world understanding of complex healthcare issues. Each session emphasizes relevant and evidence-based clinical knowledge as well as offers guidance by seasoned speakers connected to today’s practice and is open to interaction and discussion.

Credits: 17.5 credits; 15.25 are pharmacology
$470
  • Includes Credits

    Alcohol, marijuana, and tobacco are substances most commonly used by adolescents. Substance use in adolescence becomes risky, when does substance use become substance abuse? This presentation will focus on adolescent substance use and abuse. This presentation will also focus on the most commonly abused substances during adolescence, factors that contribute to substance abuse and treatment plans. | 1.50 credits (1.50 pharmacology) | $40

  • Includes Credits

    The ‘tridemic’ is threatening to overwhelm healthcare systems throughout the United States. This presentation will focus on the impact of the ‘tridemic’ and the management of common pediatric disorders. Discussion will include differential diagnosis, treatment strategies and medication management of common pediatric disorders. | 1.50 credits (1.50 pharmacology) | $40

  • Includes Credits

    The purpose of this workshop is to provide NP’s an update on the treatment of patients with HIV. It will include an overview of the issues that have impacted the uptake and use of PrEP, the newest mediations available for treatment, and a brief discussion on the impact of the end the epidemic initiatives. | 1 credits (0.75 pharmacology) | $30

  • Includes Credits

    The presentation provides practitioners with several unique concepts in preparing their patients for travel, including both land and sea destinations. | 1.50 credits (1.50 pharmacology) | $40

  • Includes Credits

    A brief overview of Allergic Asthma and when to apply the newest treatment options. The need to treat aggressively will be a focus as to avoid “remodeling” of the lungs. Using the “Step wise” approach to treatment with a few updates will help the practicing clinician decide what treatments are the best and when to initiate. Time is of the essence with a pulmonary patient and aggressive treatment and management will be the focus of this session. | 1.50 credits (1.50 pharmacology) | $40

  • Includes Credits

    Heart failure (HF) affects millions of people and is associated with substantial high morbidity and mortality, as well as high rates of hospitalization. Therefore, it is essential for practitioners to be able to diagnose and manage these individuals. Subsets of HF including HFpEF (preserved ejection fraction) and HFrEF (reduced ejection fraction) are commonly encountered in clinical practice. This session will focus on the recognition, treatment and prevention of HF, along with discussion of current guidelines that will assist practitioners to effectively manage these patients. | 1.50 credits (0.75 pharmacology) | $40

  • Includes Credits

    Atrial fibrillation (AF) remains the most common heart arrhythmia in the general population and is associated with significant morbidity and mortality. Appropriate identification and treatment are critical to prevent potential devastating sort-and long-term outcomes. Practitioners in all areas of practice will encounter patients with various stages of AF, and therefore must be able to identify, classify and treat this common arrhythmia. This session will focus on the classification of AF, identification and various treatment and preventative options. | 1.50 credits (0.75 pharmacology) | $40

  • Includes Credits

    As a result of the opioid crisis, no medical profession has come under more scrutiny, regulatory oversight, and increased legal risk than primary care providers who prescribe opioids. This course will cover DEA’s authority, an overview of current drugs of concerns and emerging drug threats, medical provider and office controlled substance risks along with case studies followed by various drug updates including fentanyl, CBD, Kratom, medication assisted treatment, drug destruction, telemedicine, DEA FAQ’s, DEA provider resources and overall provider risk mitigations safeguards. This isn’t a “theory class” from an attorney who’s never been in the courtroom or one about “recent case rulings” on one about “drug policy analysis”, but a hands-on, data driven, common sense review of problem areas from a former DEA agent with real life opioid experience. | 1.50 credits (1.0 pharmacology) | $40

  • Includes Credits

    This session will examine clinically relevant updates for managing urinary tract infections, one of the most frequently encountered infections in outpatient practice. Session topics include, [1] recent trends in urinary pathogen resistance and associated empiric approaches based on these resistance trends; [2] evidence for non-antibiotic approaches to limit recurrent urinary tract infections; [3] considerations for assessing urinary specimen results; [4] management of asymptomatic bacteriuria; and [5] anti-infective specific practice pearls throughout the session. | 1.50 credits (1.50 pharmacology) | $40

  • Includes Credits

    This session will explore clinically meaningful considerations for commonly used antibiotic classes in the outpatient setting. Antibiotic agents covered include penicillin's, cephalosporins, doxycycline, trimethoprim-sulfamethoxazole, macrolides, and fluoroquinolones. Clinical pearls include trends and changes in bacterial resistance impacting use, clinically meaningful side effects and drug interactions, unique dosing considerations to optimize efficacy. The session will also highlight new evidence impacting the use of the corresponding antibiotic agents. | 1.50 credits (1.50 pharmacology) | $40